This will be a randomized, controlled trial involving kidney and kidney pancreas transplant patients. There will be 2 groups and patients that will be randomized to one of the two groups. Clinical outcomes will be compared for those in each group and clinical differences between patients who receive routine medical therapy with IPC/TEDS versus the Geko device will also be evaluated.
This will be a randomized, controlled trial involving kidney and kidney pancreas transplant patients. There will be 2 groups and patients will be randomized to one of the two; one will receive standard of care IPC or TED stockings to help with circulation, the other group will use the geko device which is a newer device with Health Canada approval. Clinical outcomes will be compared for those in each group and clinical differences between patients who receive routine medical therapy with IPC/TEDS versus the Geko device will also be evaluated.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
London Health Sciences Centre, University Hospital
London, Ontario, Canada
Decrease in edema
As measured by patient weight and leg diameter
Time frame: Within 30 days post-transplant
Patient satisfaction
Patients will be asked to complete a questionnaire at these time points to assess their satisfaction
Time frame: 3 and 6 days after transplant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.